Protocol summary

Study aim
effect of dexmedetomidine(DEX) on postoperative nausea & vomiting(ponv) in laparoscopic cholecystectomy in addicted patients
Design
Clinical trial with control group, parallel groups, double-blind, randomized, phase 3 on 100 patients, patients with aspect ratio (1:1), receiving DEX or placebo, according to the random number generation table
Settings and conduct
100 addicted patients, laparoscopic cholecystectomy ,Shohadaye Tajrish Hosp, written consent, by random block division into 2 groups of 50 people (intervention and placebo group), DEX and placebo with shape, color, size and same packaging, A&B coding before use (not by researcher),10 minutes after induction until the end , intervention group under infusion of of DEX and placebo group under infusion of normal saline, recording information during and after operation by an experienced person (unfamiliar with the control & intervention groups), transfer to the recovery, observation and interview by trained personnel to evaluate variables (nausea,retching, vomiting, regurgitation), recording data in different minutes, making 2 files (intervention & control groups) for statistical use
Participants/Inclusion and exclusion criteria
Inclusion : Addicted ,age 20 - 60 , ASA 1& 2, SBP before & during operation between 90 - 140 mm Hg Exclusion : Laparotomy, surgery more than 4 hours, severe bleeding, ASA 3, motion sickness ,PONV, heart or GI disease, nausea & vomiting before surgery, drug withdrawal before surgery, anti-emetic drug use
Intervention groups
10 minutes after induction until the end, intervention group will undergo infusion of 1 microgram per minute DEX per kilogram of weight, placebo group will undergo N/S infusion
Main outcome variables
degrees of ponv (nausea,retcging,regurgitation ,vomiting) for intervention and control groups, main variable ponv, its degrees ,hemodynamic and demographic variables are secondary.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20230728058951N1
Registration date: 2023-10-22, 1402/07/30
Registration timing: prospective

Last update: 2023-10-22, 1402/07/30
Update count: 0
Registration date
2023-10-22, 1402/07/30
Registrant information
Name
Mohamad hosein Rezaei
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2640 9546
Email address
sepidsaman35@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-11-22, 1402/09/01
Expected recruitment end date
2024-02-19, 1402/11/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Studying effect of Dexmedetomidine on postoprative Nausea & Vomiting(PONV)In Laparascopic Cholecystectomy in Addict patient
Public title
Studying effect of Dexmedetomidine on postoprative Nausea & Vomiting(PONV)
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with a history of addiction (according to definition) Age between 20 and 60 years ASA class one and two Blood pressure 24 hours before and during the operation between 140 and 90 mmHg
Exclusion criteria:
Intraoperative laparotomy Surgery lasting more than 4 hours Heavy bleeding ASA class three Any history of heart disease History of gastrointestinal disease Presence of nausea and vomiting before surgery Drug withdrawal symptoms before surgery Taking antiemetics History of motion sickness or PONV
Age
From 20 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 100
Randomization (investigator's opinion)
Randomized
Randomization description
The sampling is random, and the allocation is done according to the table of random numbers in two groups and the ratio of one to one in the intervention and control groups is done according to the sample size formula. Receiving dexmedetomidine or placebo are assigned based on the random number generation table. Patients are divided into two groups of 50 and each patient is randomly assigned a number. The control group includes numbers 1 to 50 and the intervention group includes numbers 51 to 100.
Blinding (investigator's opinion)
Double blinded
Blinding description
100 patients with drug addiction (according to the definition), candidates for laparoscopic cholecystectomy in Shohada Tajrish Hospital, who meet the entry criteria for the study, are informed by the trained personnel about the implementation and objectives of the study, and if they wish to participate in the study A written consent form is obtained from them and then each patient is classified according to the classification made using the random block division method and placed in the group receiving dexmethomidine (intervention group) or the placebo group (control group) means 2 groups of 50 people. It should be noted that if a patient is removed from the study for any reason, a person who has no knowledge of the intervention group and the control group will be randomly replaced with a new patient who meets the criteria for entering the project. With this process, the number of evaluated patients may exceed 100. Before the operation, each patient is interviewed by an anesthesiologist and demographic, hemodynamic, history and entry criteria are collected and the information is recorded in the relevant form. Dexmethomidine and placebo drugs are prepared with the same shape, color, size and packaging and are coded as A&B before injection by a person other than the researcher. The group under intervention with dexmethomidine drug 10 minutes after induction under dexmethomidine infusion 1 mcg/kg /min is placed and this continues until the end of the operation. And the placebo group also receives normal saline infusion 10 minutes after induction until the end of the procedure. The information is recorded from the time of arrival until 120 minutes later by the medical evaluator who does not know the type of patient group. After collecting all the information of the patients, this information will compiled into two files (the intervention group with dexmedetomidine and the control group with placebo) and will be used statistically.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shahid Beheshti University of Medical Sciences
Street address
13th floor, Block A, Central Headquarters of the Ministry of Health, Treatment and Medical Education, Simai Iran Street, between South Flamak St. and Zarafshan, Quds Town (West Town ), Tehran
City
Tehran
Province
Tehran
Postal code
1467664961
Approval date
2023-05-29, 1402/03/08
Ethics committee reference number
IR.SBMU.MSP.REC.1402.105

Health conditions studied

1

Description of health condition studied
Effect of dexmedetomidine on postoperative nausea and vomiting (PONV)
ICD-10 code
R11
ICD-10 code description
Nausea and vomiting

Primary outcomes

1

Description
Post operative Nausea and vomiting (ponv) is one of the most unpleasant experiences that has important consequences on patient satisfaction, treatment results and related costs, and is one of the common causes of morbidity after surgery. Grades of (ponv) include nausea, retching, regurgitation or vomiting.  ponv:It is one of the common causes of morbidity after surgery, which usually occurs during the recovery phase and ends spontaneously within 24 hours.it includes nausea that can end in retching or vomiting or regurgitation.  Nausea:This is an unpleasant feeling that refers to the urge to vomit and is not accompanied by muscle movement outside the driver.  Vomiting:It is the strong excretion of even small amounts of the contents of the upper GI tract through the mouth.  Regurgitation:It is the exit of material from the pharynx or esophagus with low pressure, which is usually characterized by the presence of undigested food or blood.  Retching:When even with muscular ejector efforts, no contents of the stomach are expelled through the mouth.
Timepoint
Measurement of presence Post operative nausea & vomitting and its levels in 15, 30, 45, 60, 90 and 120 minutes after the operation
Method of measurement
The interview includes asking the patient or the patient's complaint (in cases of nausea and regurgitation) and observation (in cases of vomiting and retching).

Secondary outcomes

1

Description
The secondary outcome variables are the degrees of postoperative nausea and vomiting including: nausea, regurgitation, retching, and vomiting, which were explained earlier.
Timepoint
Measuring the degree of postoperative nausea and vomiting in 15, 30, 45, 60, 90 and 120 minutes after the surgery.
Method of measurement
The interview includes asking the patient or the patient's complaint (in cases of nausea and regurgitation) and observation (in cases of vomiting and retching).

Intervention groups

1

Description
intervention group: The intervention group (including 50 people) will be subjected to intravenous infusion of dexmethomidine (an alpha 2 agonist drug) with dose of 1 mcg/kg/min, just from 10 minutes after induction of anesthesia until the end of the operation.
Category
Prevention

2

Description
Control group: The placebo group was given intravenous infusion of normal saline (0.9% saline), which is a physiological liquid,just from 10 minutes after induction of anesthesia until the end of the procedure.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Shohadaye Tajrish Hospital
Full name of responsible person
Hamideh Ariannia
Street address
Shohadaye Tajrish Educational Medical Center,Shahadari St.,Tajrish Square
City
Tehran
Province
Tehran
Postal code
1989934148
Phone
+98 21 2271 8000
Email
ham.ariannia@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Houman Teymurian
Street address
Shohadaye Tajrish Educational Medical Center,Shahadari St.,Tajrish Square
City
Tehran
Province
Tehran
Postal code
1989934148
Phone
+98 21 2271 8001
Email
houman72625@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohamad Hosein Rezaei
Position
ANESTHESIOLOGY RESIDENT
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Unit21- No3 - Peyvandi St - Dastgerdi St - Shariati Ave
City
Tehran
Province
Tehran
Postal code
1911853173
Phone
+98 21 2640 9546
Email
sepidsaman35@gmail.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Houman Teymurian
Position
استاد دانشگاه (رشته بیهوشی)
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Shohadaye Tajrish Educational Medical Center,Shahadari St.,Tajrish Square
City
Tehran
Province
Tehran
Postal code
1989934148
Phone
+98 21 2271 8002
Email
houman72625@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohamad Hosein Reaei
Position
Anesthesiology Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Unit21- No3 - Peyvandi St - Dastgerdi St - Shariati Ave
City
Tehran
Province
Tehran
Postal code
1911853173
Phone
+98 21 2640 9546
Email
sepidsaman35@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Not applicable
Title and more details about the data/document
All the necessary information according to the regulations of the desired journal to print the article is available in the file sent to the journal office.
When the data will become available and for how long
Until the publication of the article
To whom data/document is available
all of people
Under which criteria data/document could be used
For public use, especially in the country's health sector
From where data/document is obtainable
Magazine office
What processes are involved for a request to access data/document
The desired and prescribed procedures of the journal office for publication and printing of articles
Comments
The useful point cannot be mentioned
Loading...